Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 81,068,438
- Total 13F value
- $1,228,198,230
- Share change
- +828,482
- Put/Call ratio
- 3.5%
- SEC-reported price per share
- $15.15
- Number of holders
- 118
- Value change
- -$21,970,408
- Number of buys
- 60
- Number of sells
- 68
- Shares outstanding
- 94,920,069
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
118
Top holders
10
ZNTL full security history
Ownership snapshot
Full 13F holder table
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
Matrix Capital Management Company, LP leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership
Top 5
Matrix Capital Management Company...
15%
FMR LLC
10%
EVENTIDE ASSET MANAGEMENT, LLC
8.2%
VANGUARD GROUP INC
5.5%
BlackRock Finance, Inc.
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
Company
|
15%
|
$280,037,058
13,959,973 shares
|
— | 30 Sep 2023 |
| FMR LLC |
13F
Company
|
10%
|
$190,447,555
9,493,896 shares
|
— | 30 Sep 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
8.2%
|
$156,749,622
7,814,039 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
5.5%
|
$105,047,460
5,236,663 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
4.6%
|
$88,180,890
4,395,857 shares
|
— | 30 Sep 2023 |
| Capital International Investors |
13F
Company
|
3.3%
|
$62,742,825
3,127,758 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
118
Shares
81,068,438
Rows available
118
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
136
Q4 2023 holders
118
Holder diff
-18
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|